## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the firstβline treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi
β¦ LIBER β¦
An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)
β Scribed by Norma Jung; Matthias Hellmann; Reimund Hoheisel; Clara Lehmann; Ingo Haase; Andreas Perniok; Michael Hallek; Andrea Rubbert
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 114 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The efficacy of reboxetine in the treatm
β
P. N. Dannon; I. Iancu; L. Grunhaus
π
Article
π
2002
π
John Wiley and Sons
π
English
β 57 KB
π 2 views
Almotriptan in the acute treatment of mi
β
J. A. Charles
π
Article
π
2006
π
Springer
π
English
β 31 KB
Long-term open-label preliminary study o
β
Earl Silverman; Lynn Spiegel; David Hawkins; Ross Petty; Donald Goldsmith; Laura
π
Article
π
2005
π
John Wiley and Sons
π
English
β 151 KB
π 2 views
Efficacy and Safety of a Combination The
β
G. Keyszer; C. Keysser; M. Keysser
π
Article
π
1999
π
Springer
π
English
β 138 KB
An open study of the efficacy and safety
β
A. P. MacGowan; R. A. Bailey; W. Egner; D. M. Picken; D. S. Reeves
π
Article
π
1990
π
Springer-Verlag
π
English
β 389 KB
Open-label flexible-dose pilot study to
β
Joseph H. Friedman; Robert M. Berman; Christopher G. Goetz; Stewart A. Factor; W
π
Article
π
2006
π
John Wiley and Sons
π
English
β 57 KB
π 2 views
## Abstract Psychosis affects at least 5% to 8% of medicationβtreated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PDβrelated motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr